The largest global research initiative aimed at tackling the challenge of neurodegenerative diseases.
[email protected]  |  
JPND Neurodegenerative Disease Research

Search

Menu

  • About
  • Activities
  • Projects
  • PPI
  • CSA BrainHealth
  • Data Hubs
    • Research Database
    • Global Cohort Portal
    • Experimental Models for Parkinson’s Disease
  • EU Research Infrastructure Access
  • News & Media
  • Join Us
    • About
    • Activities
    • Projects
    • PPI
    • CSA BrainHealth
    • Data Hubs
      • Research Database
      • Global Cohort Portal
      • Experimental Models for Parkinson’s Disease
    • EU Research Infrastructure Access
    • News & Media
    • Join Us
4 – Interviews with JPND Chair, SAB Chair and SAB Members
Home » Major Activities » JPND/JPcofuND Symposiums » JPND SYMPOSIUM 2019 » 4 – Interviews with JPND Chair, SAB Chair and SAB Members
  • 2019 Research and Innovation Strategy
    • Interview with SAB Chair Professor Thomas Gasser
    • Stakeholder Consultation
    • Workshops & Questionnaire
      • Precision Medicine Workshop
      • Public Health Workshop
      • Questionnaire on Non-Human Primates
  • JPND/JPcofuND Symposiums
    • JPND SYMPOSIUM 2019
      • 1 – Symposium Video
      • 2 – Photo Gallery
      • 3 – Scientific Sessions
        • Biomarkers
          • ADAGE: Pietro CORTELLI
          • BIOMARKAPD: Bengt WINBLAD
        • Disease Modelling and Target Identification
        • Genetics and Environmental Risk Factors
          • RiMod-FTD: Peter HEUTINK
        • Genetics-causative factors
          • EADB: Jean-Charles LAMBERT
        • Genomics and Epigenetics
        • Healthcare, Prevention and Treatment
          • MEETINGDEM
          • MIND-AD: Miia KIVIPELTO
        • Protein Misfolding
          • NeuTargets: Chiara Zurzolo
        • Synaptics and Molecular Mechanisms
          • INCURE
      • 4 – Interviews with JPND Chair, SAB Chair and SAB Members
        • a – Philippe Amouyel, JPND Chair
        • b – Thomas Gasser, SAB Chair
        • c – Stefano Cappa, SAB Member
        • d – Myrra Vernooij-Dassen, SAB Member
        • d – Philip Scheltens, SAB Member
      • 5 – Presentation Slides
      • 6 – Interviews with Winners of the Young Scientist Poster Prize
        • Luca Kleineidam – EADB
        • Niamh M. C. Connolly – CeBioND
        • Vincent Baudouin – PrPCPDK1
    • JPND SYMPOSIUM 2022
      • 1 – Symposium Video
      • 2 – Photo Gallery
      • 3 – Scientific Sessions
        • Health and Social Care
        • Pathway Analysis
        • Personalised Medicine
      • 4 – Interviews with JPND chair and SAB chair
        • a – Philippe Amouyel, JPND Chair
        • b – Thomas Gasser, SAB Chair
      • 6 – Young Scientist Poster Prize Awards
    • JPND SYMPOSIUM 2024
      • 1 – Symposium Video
      • 2 – Photo Gallery
      • 3 – Scientific Sessions
        • LINKING PRE-DIAGNOSIS DISTURBANCES OF PHYSIOLOGICAL SYSTEMS (2021)
        • NOVEL IMAGING AND BRAIN STIMULATION METHODS (2020)
        • PERSONALISED MEDICINE (2019)
      • 4 – Interviews with JPND chair and SAB members
      • 5 – Interview with PPI Advisory Board Members
      • 6 – Young Scientist Poster Prize Awards
  • 2012 Research Strategy
    • Delivery of the Research Strategy
    • Expert workshops
      • Basic Research
      • Clinical Research
      • Healthcare Research
      • Final Workshop
    • Stakeholder Consultations
      • Industry Meeting
      • Patient and Carer Meeting
      • Online Consultation
      • One-to-One consultations
    • Launch of the 2012 Research Strategy
  • JPco-fuND 2
  • Operating Plan
    • Implementation Plan, 2012-2014
  • Alignment Actions
    • Alignment of National Strategies
    • Alignment of National Activities
    • Longitudinal Cohorts
      • Call for Working Groups
        • Cohort Working Groups
        • Reports
        • FAQ + Webinar
          • FAQ
        • Interview with Philippe Amouyel
    • Assisted Living Technologies
    • Industry Partnership
    • Animal and Cell Models
    • Palliative Care
    • Patient + Public Involvement
      • PPI Stakeholder Advisory Board
    • Optimisation of biomarkers
  • JPco-fuND
  • Annual Calls for Proposals
    • 2025 RESEARCH CALL ON HEALTH AND SOCIAL CARE RESEARCH WITH A FOCUS ON THE MODERATE AND LATE STAGES OF NEURODEGENERATIVE DISEASES
      • Country-Specific Details
    • Call Statistics
    • Closed Calls
      • 2020 Research Call on “Novel Imaging and Brain Stimulation Methods and Technologies Related to Neurodegenerative Diseases”
        • Country-Specific Details
        • Novel Imaging and Brain Stimulation Methods and Technologies Projects
      • 2021 Expert Working Groups Call On “THE IMPACT OF COVID-19 ON NEURODEGENERATIVE DISEASE RESEARCH” 
        • Results of the 2021 JPND Working Groups Call: The Impact of Covid-19 on Neurodegenerative Disease Research
      • 2021 Research Call on “LINKING PRE-DIAGNOSIS DISTURBANCES OF PHYSIOLOGICAL SYSTEMS TO NEURODEGENERATIVE DISEASES”
        • Country-Specific Details
        • Linking Pre-Diagnosis Disturbances of Physiological Systems to Neurodegenerative Diseases Projects
      • 2022 EXPERT WORKING GROUPS CALL ON “CONCEPTS FOR HEALTH AND SOCIAL CARE RESEARCH FOR NEURODEGENERATIVE DISEASES”
        • RESULTS OF THE 2022 JPND EXPERT WORKING GROUPS CALL FOR “CONCEPTS FOR HEALTH AND SOCIAL CARE RESEARCH FOR NEURODEGENERATIVE DISEASES”
      • 2022 Research Call on “UNDERSTANDING THE MECHANISMS OF NON-PHARMACOLOGICAL INTERVENTIONS”
        • Country-Specific Details
        • Understanding the Mechanisms for Non-Pharmacological Interventions Projects
      • 2023 RESEARCH CALL ON “LARGE SCALE ANALYSIS OF OMICS DATA FOR DRUG-TARGET FINDING IN NEURODEGENERATIVE DISEASES”
        • Country-Specific Details
        • Large Scale Analysis of OMICS Data for Drug-Target Finding in Neurodegenerative Diseases Projects
      • 2023 Working Groups Call on “Use of Digital Technologies in Neurodegenerative Disease Research and Clinical Practice”
        • Results of the 2023 Working Groups Call: Use of Digital Technologies in Neurodegenerative Disease Research and Clinical Practice
      • 2024 RESEARCH CALL ON “MECHANISMS AND MEASUREMENT OF DISEASE PROGRESSION IN THE EARLY PHASE OF NEURODEGENERATIVE DISEASES”
        • Country-Specific Details
        • MECHANISMS AND MEASUREMENT OF DISEASE PROGRESSION IN THE EARLY PHASE OF NEURODEGENERATIVE DISEASES PROJECTS
      • PRE-CALL ANNOUNCEMENT FOR JPND 2023 CALL: LARGE SCALE ANALYSIS OF OMICS DATA FOR DRUG-TARGET FINDING IN NEURODEGENERATIVE DISEASES
      • PRE-CALL ANNOUNCEMENT FOR JPND 2023 WORKING GROUPS CALL: USE OF DIGITAL TECHNOLOGIES IN NEURODEGENERATIVE DISEASE RESEARCH AND CLINICAL PRACTICE
      • 2019 Research Call on “Personalised Medicine”
        • Personalised Medicine Projects
        • Country-Specific Details
      • Health and Social Care 2018
        • Country-specific details
        • Health and social care projects
      • Pathways 2017
        • Country-specific details
        • Pathways projects
      • Brain Imaging Working Groups 2016
        • Brain Imaging Working Groups
        • FAQ
        • Final Reports
      • Risk Factors, Models and Cohorts 2015
        • JPND / JPco-fuND Symposium 2019
        • Call topics synopsis
          • Specific regulations
          • FAQ
            • General Framework
            • Building a consortium
            • Writing a Proposal
            • Evaluation and Decision
        • JPco-fuND Intermediate Symposium
        • JPco-fuND Projects
        • Monitoring Report
        • Survey of call applicants
      • Preventive Strategies 2013
        • Preventive Strategy Pilot Projects
        • National-level details
      • Cross-Disease Analysis 2013
        • Country-specific details 2013
        • Cross-Disease Analysis Projects
      • Healthcare Evaluation 2012
        • Healthcare Evaluation Projects
          • ActifCare
          • ALS-CarE
          • CLASP
          • MEETINGDEM
          • RHAPSODY
          • NEEDS in ALS
      • Risk Factors 2012
        • Risk Factor Projects
          • APGeM
          • COURAGE-PD
          • PERADES
          • RiMod-FTD
          • STRENGTH
      • Biomarkers Call 2011
        • National Contact Representatives
        • Biomarker Projects
          • BIOMARKAPD
          • CSFQUIC
          • DEMTEST
          • SOPHIA
  • Network of Centres of Excellence
    • Results of the Fourth CoEN Call
    • Results of Third CoEN Call
    • Participating Centres of Excellence
    • Results of First CoEN Call
    • Results of Second CoEN Call
  • Research Mapping
    • 2016 Report
    • Data Collected
    • 2011 Report
  • Monitoring and Evaluation
  • Linked Activities

JPND SYMPOSIUM 2019

Interviews with JPND Chair, SAB Chair and SAB Members

JPND Chair, Professor Philippe Amouyel, its Scientific Advisory Board (SAB) Chair, Professor Thomas Gasser and some of the SAB’s members share their thoughts about the symposium and the crucial roles JPND play in the support of the projects and the success of the event:

  • Philippe Amouyel, JPND Chair
  • Thomas Gasser, SAB Chair
  • Stefano Cappa, SAB Member
  • Myrra Vernooij-Dassen, SAB Member
  • Philip Scheltens, SAB Member

VIEW ALL JPND NEWS & MEDIA

footer-logo

The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases, in particular, Alzheimer’s.

Join Us

Twitter Feed

Tweets by @JPNDeurope

Contact Us

General enquiries: [email protected]

This initiative has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements No. 643417, No. 681043 and No. 825664.

EU emblem

©2023 JPND Research | Privacy Policy | Cookie Policy |  Hosted By SmartHost | Site by Ten10